THE presence of aii iiiiiibitor of oncolvsis in the ascitic fluid from the Elirlicli ascites carcinoma has been invoked previously (Hartveit, 1963b) (Ponder, 1948).
Received foi-publication Atigust 1, 1964 THE presence of aii iiiiiibitor of oncolvsis in the ascitic fluid from the Elirlicli ascites carcinoma has been invoked previously (Hartveit, 1963b) to explain the survival of this tumour oii homotransplaiitation. Lysed cells are present, in early transplaiits of this tumour, when the proteiii conteilt of the ascites is low. whiie thev are not found in later transplants in which the protein content has' beeii sho-%vn to be higher. It was felt that the increase in the proteiii conteiit might be respoiisible for this inhibition of lysis, particularly as the serum proteins in general show ai-i iiihibitor action on haemolytic reactions (Ponder, 1948) .
-NA-hich have beeii shown to be akin to the oncolytic reactioii (Hartveit, 1965) .
As, from the above-meiitioiied studies, it seemed possible that it is an inhibitor of Ivsis rather than lack of complement that puts a stop to the lvtic reactioii tn vtvo it was decided to iiivestigate the result of adding complement to the tumour cells aiid testing the effect of tumour ascitic fluid on the oncolvtic reactioii in vitro. Humai-i serum was used as the source of complement as tilis has beeii iised in most of the work oii the oncolytic reaction (see Hartveit, 1965) .
The effect of tumour ascitic fluid from tumour transplaiits of differeiit ages -%vas tested with many sera, serum-cell conceiitrations ai-id on tumour trai-isplai-its of different ageq. As the results were similai, in all cases oiilv specimen experimeiits will be reported here.
MATERIAL AND METHODS
The Ehrlich ascites carcinoma, the mice aiid the humaii sera used weresimilar to those used in previous experimeiits (Hartveit, 1965a. b) . A oiie in 20 suspension of whole tumour ascites in phvsiological saline was used for the tumour cell suspensioii. The ttiLmour cells were takeii from a pykiiotic transplaiit. i.e. oiie that contaiiied iio lysed cells (Hartveit, 1963a) . The humaii sera were used either uiidiluted or after dilutioii in phvsiological saliiie. Tumour ascitic fluid was obtained after removiiig the cells bv ceiitrifugatioii. This fluid was used either fresh or after storage at -20' C. it was used whole or after dilutioii m-ith physiological saline.
The cell-serum-ascitic fluid mixtures NN-ere The results of both experimeiits show that the iiihibitor is effective at 20' C.
-aii(I at 37' C.
DISCUSSION
The preseiit experiment has demonstrated that tumour ascitic fluid from the Ehrlich ascites carciiioma has a markedlv inhibitorv effect on the oncolytic -activitv of humaii serum oii Ehrlicli ascii'es careiiioma cells. If. as has beeii sitYgested previously (Hartveit, 1965) (Hartveit, 1963b) , the conclusioji reached being that it was more likelv that aii iiihibitoiwas preseiit than that the reaction was limited bv lack of complemeiit. Ttie preseiit experimeiit supports this view as if lack of complemeiit in the ascitic fluid were the i-eason for lack of lysis in late transplaiits in vivo the ascitic fluid should have iio iiihibitiiig effect oii the oncolytic reactioii in vitro.
In addition it has beeii shown that this tumour ascitic fluid does iiot lack CI-i.e. it, caii be fullv complemented in the immtiiie haemolytic system bv the additioii of RI, and ftirthermore the ascitic fluid is not aiiticomplimeiitary in that system (Hartveit. 1964) . If Cl is preseiit the oiicolytic reactioii can start aiid Ci will be used up Ieven in the absence of the other compoiieiits. So, as some CI is still present.. lack of the last three components caniiot explaiii the lack of lvsis in vivo. This agaiii is in accordance with the findiiig in the present experiment that an inhibitor of lysis is preseiit in the tumotir ascitic fluid. The identity of this-inhibitor and its mode of actioii remaiii to be determiiied.
SUMMARY
The preseiiee of aii iiiiiibitor of lysis in the ascitic fluid from the Elirlieli ascites careiiioma is demonstrated in aii oncolvtic system coiisistiiig of Ehrlich ascites carcinoma cells aild humaii serum. fhe activitv of this iiihibitor appears to iiierease with the age of the tiimour transplaiit from which it is, taken. It is active at both 20 and 37' C.
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